Amundi Vertex Pharmaceuticals Inc Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Amundi holds 3,759,236 shares of VRTX stock, worth $1.7 Billion. This represents 0.66% of its overall portfolio holdings.

Number of Shares

3,759,236

Previous 3,504,059 7.28%

Holding current value

$1.7 Billion

Previous $1.64 Billion 6.45%

% of portfolio

0.66%

Previous 0.65%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $117 Million - $129 Million	255,177 Added 7.28%	3,759,236 $1.75 Billion
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $31 Million - $38.4 Million	-79,024 Reduced 2.21%	3,504,059 $1.64 Billion
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $353 Million - $386 Million	864,966 Added 31.82%	3,583,083 $1.5 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $266 Million - $318 Million	774,696 Added 39.86%	2,718,117 $1.11 Billion
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $101 Million - $108 Million	297,580 Added 18.08%	1,943,421 $676 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $124 Million - $138 Million	-393,077 Reduced 19.28%	1,645,841 $579 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $25.9 Million - $29.5 Million	-91,279 Reduced 4.29%	2,038,918 $642 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $87.1 Million - $98 Million	304,875 Added 16.7%	2,130,197 $615 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $245 Million - $273 Million	893,935 Added 95.98%	1,825,322 $551 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $79.6 Million - $99.1 Million	338,889 Added 57.2%	931,387 $267 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $51.2 Million - $60.4 Million	-231,256 Reduced 28.07%	592,498 $163 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $23.7 Million - $29.9 Million	133,856 Added 19.4%	823,754 $187 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $2.93 Million - $3.28 Million	16,172 Added 2.4%	689,898 $125 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $126 Million - $149 Million	673,726 New	673,726 $136 Million

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account